PepSee goes public — a new software tool for therapeutic peptide analysis & design

webinar

Thu, 25 Jan 2018, 16:00 CET (Berlin)

Dr. Marcus Gastreich, BioSolveIT GmbH, St. Augustin, Germany

PepSee goes public — a new software tool for therapeutic peptide analysis & design

In collaboration with Zealand Pharma, a leading and experienced therapeutic peptide specialist in Copenhagen, we conceived a tool with the major focus of having it rolled-out and operational ASAP, targeting the most relevant problems and most ugly time-eaters first thus boosting the efficiency of the organization. After approx. 2 years, we can now roll out the tool in its current status to the general public, and academics can use it for free.

PepSee sports, amongst others:

  • visual pattern recognition support for SAR work
  • versatile colorings, for ex. by mutation differences to a reference peptide
  • a plethora of sorting and filtering facilities
  • FASTA, PLN, and TXT import
  • XLS export
  • on-the-fly alignment including manual intervention
  • interfaces to predictive methods such as fibrillation highlighting, and allows validation and registration of new sequences
  • A first PDF text mining function pulling peptides from patents et al.

Current news

A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on
category
Software
Make It Double! — SeeSAR and HPSee Updates
October 14, 2026 08:00 CEST
The SeeSAR 15.1 and HPSee 2.4 Updates SeeSAR 15.1 ‘Apollo’ and HPSee 2.4 ‘Electra’ are here! The double release brings per-synthon estimates of extension result counts to Chemical Space Docking and new reference-molecule support and automatic best-spot selection to Activity Spotter. Alongside these additions, faster molecule transfers and more flexible...
Read on
Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on